Opinion editor's note: Star Tribune Opinion publishes a mix of national and local commentaries online and in print each day. To contribute, click here.
•••
Until last week, a collection of bills advancing Democrats' extreme agenda to transform Minnesota's health care system had been quietly advancing through the legislative process. Then news broke that the Mayo Clinic had sent an email to DFL legislative leaders and Gov. Tim Walz warning that, if two policies become law, Mayo will redirect billions in planned investments to other states.
Mayo's ultimatum reflects the broader reality of what will happen to Minnesota's health system if the full package of far-left policies become law. Together, they collect the worst of top-down, government-knows-best regulations and will cement Minnesota's position as the most tightly regulated health care state, undermining future investment and innovation to deliver better patient care.
Unfortunately, patients have no idea what is coming because every major player in the health sector has focused on protecting its own turf and otherwise has kept quiet. Worse, they've turned on each other in a blame game trying to deflect the damage from DFL policies onto other players. Like most circular firing squads, it's not gone well.
Early on, the Association for Accessible Medicines, which represents generic drug manufacturers, urged legislators to remove price controls on generics from a bill and, instead, focus on high-cost brand-name drugs.
To defend branded drug manufacturers against price caps in the same bill, their lobbying arm PhRMA highlighted how insurers and pharmacy benefit managers (PBMs) contribute to higher drug costs. PhRMA even itemized several top-down government regulations legislators should impose on these players.
Eventually, the Minnesota Council of Health Plans — the PBM's cobelligerent against PhRMA — weighed in against the drug manufacturers with unequivocal support for drug price controls.